Source: | This article originally belongs to thehealthsite.com
You May Also Like
WHO suspends hydroxychloroquine clinical trial on COVID-19 patients – but why?
Many countries, including India, has been using anti-malaria drug hydroxychloroquine (HCQ) as…
- shalw
- January 13, 2021
SII to seek emergency use authorisation for AstraZeneca COVID-19 vaccine Covishield in 2 weeks
The Serum Institute of India (SII) will seek emergency use authorisation for…
- shalw
- January 13, 2021